Jump to main content
Jump to site search

Issue 8, 2019
Previous Article Next Article

Derivatisation of parthenolide to address chemoresistant chronic lymphocytic leukaemia

Author affiliations

Abstract

Parthenolide is a natural product that exhibits anti-leukaemic activity, however, its clinical use is limited by its poor bioavailability. It may be extracted from feverfew and protocols for growing, extracting and derivatising it are reported. A novel parthenolide derivative with good bioavailability and pharmacological properties was identified through a screening cascade based on in vitro anti-leukaemic activity and calculated “drug-likeness” properties, in vitro and in vivo pharmacokinetics studies and hERG liability testing. In vitro studies showed the most promising derivative to have comparable anti-leukaemic activity to DMAPT, a previously described parthenolide derivative. The newly identified compound was shown to have pro-oxidant activity and in silico molecular docking studies indicate a prodrug mode of action. A synthesis scheme is presented for the production of amine 7 used in the generation of 5f.

Graphical abstract: Derivatisation of parthenolide to address chemoresistant chronic lymphocytic leukaemia

Back to tab navigation

Supplementary files

Publication details

The article was received on 28 May 2019, accepted on 03 Jul 2019 and first published on 01 Aug 2019


Article type: Research Article
DOI: 10.1039/C9MD00297A
Med. Chem. Commun., 2019,10, 1379-1390
  • Open access: Creative Commons BY license
  •   Request permissions

    Derivatisation of parthenolide to address chemoresistant chronic lymphocytic leukaemia

    X. Li, D. T. Payne, B. Ampolu, N. Bland, J. T. Brown, M. J. Dutton, C. A. Fitton, A. Gulliver, L. Hale, D. Hamza, G. Jones, R. Lane, A. G. Leach, L. Male, E. G. Merisor, M. J. Morton, A. S. Quy, R. Roberts, R. Scarll, T. Schulz-Utermoehl, T. Stankovic, B. Stevenson, J. S. Fossey and A. Agathanggelou, Med. Chem. Commun., 2019, 10, 1379
    DOI: 10.1039/C9MD00297A

    This article is licensed under a Creative Commons Attribution 3.0 Unported Licence. Material from this article can be used in other publications provided that the correct acknowledgement is given with the reproduced material.

    Reproduced material should be attributed as follows:

    • For reproduction of material from NJC:
      [Original citation] - Published by The Royal Society of Chemistry (RSC) on behalf of the Centre National de la Recherche Scientifique (CNRS) and the RSC.
    • For reproduction of material from PCCP:
      [Original citation] - Published by the PCCP Owner Societies.
    • For reproduction of material from PPS:
      [Original citation] - Published by The Royal Society of Chemistry (RSC) on behalf of the European Society for Photobiology, the European Photochemistry Association, and RSC.
    • For reproduction of material from all other RSC journals:
      [Original citation] - Published by The Royal Society of Chemistry.

    Information about reproducing material from RSC articles with different licences is available on our Permission Requests page.

Search articles by author

Spotlight

Advertisements